DUBLIN–(BUSINESS WIRE)–The “Intravenous Solutions Market, by Solution, by Bag Type, by Application, by End User, and by Region – Size, Share, Outlook, and Opportunity Analysis, 2022 – 2030” report has been added to ResearchAndMarkets.com’s offering.
Intravenous solutions are fluids, which are administrated to a patient directly into the venous circulation. These fluids are sterile, non-pyrogenic solutions used for fluid replenishment and caloric supply in single dose container for intravenous administration. There are various types of intravenous solutions available in the market such as sodium chloride, lactated ringers, dextrose in water, and others. Intravenous therapy is ideal for patients suffering from nutritional deficiency and dehydration. Dehydration can contribute to various affects such as
Balance of important minerals (electrolytes) in the body.
Cognitive (mental) performance.
Energy level.
Gastrointestinal function (your ability to digest food and create pee and poop).
Headache frequency and intensity.
Physical performance.
Skin health.
Market Dynamics
Increasing prevalence of diarrhoea is expected to boost the global intravenous solution market growth over the forecast period. For instance, in July 2022, UNICEF (United Nations International Children’s Emergency Fund), an agency of the United Nations responsible for providing humanitarian and developmental aid to children worldwide, published a report which accounted for 9 per cent of all deaths among children under age 5 worldwide in 2019 due to Diarrhoea, whereas over 1,300 young children dying each day, or about 484,000 children a year globally due to diarrhoea.
Moreover, according to an article published in the Lancet Infectious Diseases, September 2018, diarrhoea was the third leading cause of disability-adjusted life year (DALYs) in 2016, which accounted for 74.4 million DALYs, globally. According to the same source, diarrhoea was the eighth leading cause of death, which accounted for 1,655,944 deaths in 2016 globally.
Key features of the study:
This report provides an in-depth analysis of the global intravenous solutions market, market size (US$ Mn), and compound annual growth rate (CAGR (%)) for the forecast period: 2022 – 2030, considering 2021 as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by leading players
It profiles key players in the global intravenous solutions market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launches, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
The global intravenous solutions market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, suppliers, research and consulting firms, new entrants, and financial analysts
Stakeholders would have ease in decision making through various strategy matrices used in analyzing the global intravenous solutions market.
Detailed Segmentation:
Global Intravenous Solutions Market, By Solution type:
Saline
Normal Saline (0.9% NaCl)
Hypertonic Saline
Dextran
Lactated Ringer’s
Amino Acid
Vitamins & Minerals
Heparin and Trace Elements
Mixed Solutions
Global Intravenous Solutions Market, By Bag type:
Large Volume Bags (greater than 250ml)
Small Volume Bags (less than 250ml)
Global Intravenous Solutions Market, By Application:
Basic IV Solution
Nutritional IV Solution
Blood IV Solution
Drug IV Solution
Irrigation IV Solution
Global Intravenous Solutions Market, By End User:
Hospitals
Clinics
Ambulatory Surgery Centers
Home Care Settings
Global Intravenous Solutions Market, By Region:
North America
By Country
U.S.
Canada
Latin America
By Country
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Country
U.K.
Germany
Italy
Spain
France
Russia
Rest of Europe
Asia Pacific
By Country
Australia
India
China
Japan
ASEAN
South Korea
Rest of Asia Pacific
Middle East
By Country
GCC
Israel
Rest of Middle East
Africa
By Country
South Africa
Central Africa
North Africa
Key Topics Covered:
1. Research Objectives and Assumptions
2. Market Purview
3. Market Dynamics, Regulations, and Trends Analysis
4. Global Intravenous Solutions Market- Impact of Coronavirus (Covid-19) Pandemic
5. Global Intravenous Solutions Market, By Solution Type, 2017 – 2030, (US$ Million)
6. Global Intravenous Solutions Market, By Bag Type, 2017 – 2030, (US$ Million)
7. Global Intravenous Solutions Market, By Application, 2017 – 2030, (US$ Million)
8. Global Intravenous Solutions Market, By End User, 2017 – 2030, (US$ Million)
9. Global Intravenous Solutions Market, By Region, 2017 – 2030, (US$ Million)
10. Competitive Landscape
11. Section
Companies Mentioned
Baxter International Inc.
ICU Medical, Inc.
Braun Melsungen Ag
Grifols, S.A.
Fresenius Kabi USA, LLC
Vifor Pharma Management Ltd.
JW Life Science
Amanta Healthcare
Axa Parenterals Ltd.
Salius Pharma Private Limited.
Pfizer, Inc.
Otsuka Pharmaceutical Co., Ltd
Ajinomoto Co., Inc.
Braun Melsungen AG
Soxa Formulations & Research Pvt. Ltd
Sichuan Kelun Pharmaceutical Co Ltd
For more information about this report visit https://www.researchandmarkets.com/r/93mry1.
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
